Skip to content
DataLookout
Menu

Larimar Therapeutics, Inc. clinical trial pipeline

Get alerts when Larimar Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: FORWARD-FA · Subcutaneous Nomlabofusp · Friedreich's Ataxia Start date changed from estimate of Oct 26, 2026 to Aug 5, 2026 Larimar Therapeutics, Inc.Phase 3 NCT07778836
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 2
1
Phase 3
1
Get alerts when Larimar Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free